Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jun;13(2):197.
doi: 10.1007/s13181-017-0608-6. Epub 2017 Mar 9.

In Response to: Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review

Affiliations
Comment

In Response to: Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review

Joanne C Routsolias. J Med Toxicol. 2017 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

None.

Sources of Funding

None.

Comment in

Comment on

References

    1. Sorensen CJ, Desanto K, Borgelt L, et al. Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment—a systematic review. J Med Toxicol. 2016; 3(1):71-87. - PMC - PubMed
    1. Sun S, Zimmermann AE. Cannabinoid hyperemesis syndrome. Hosp Pharm. 2013;48(8):650–655. doi: 10.1310/hpj4808-650. - DOI - PMC - PubMed
    1. Sullivan S. Cannabinoid hyperemesis. Can J Gastroenterol. 2010;24(5):284–285. doi: 10.1155/2010/481940. - DOI - PMC - PubMed
    1. Wallace EA, Andrews SE, Garmany CL, Jelley MJ. Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm. SMJ. 2011;104(9):659–664. doi: 10.1097/SMJ.0b013e3182297d57. - DOI - PubMed
    1. Witsil J, Mycyk MB. Haloperidol, a novel treatment for cannabinoid hyperemesis syndrome. Am J Ther. 2017;24:e64–e67. doi: 10.1097/MJT.0000000000000157. - DOI - PubMed

LinkOut - more resources